Juarez, M., Diaz, N., Johnston, G. I., Nayar, S., Payne, A., Helmer, E., Cain, D., Williams, P., Ng, W. F., Fisher, B., Gottenberg, J., Guggino, G., Mariette, X., Kvarnström, M., Devauchelle-Pensec, V., Rosas, J., Sanchez-Burson, J., Giacomelli, R., Barone, F., & Bowman, S. J. (n.d.). aB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (PSS). Annals of the rheumatic diseases, 78, 1692–1693. http://access.bl.uk/ark:/81055/vdc_100144720252.0x000054